The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library

Immunopharmacology

Volumn 45, Issue 1-3, 1999, Pages 83-88

  Rae, Fiona ^a   Bulmer, Bronwyn ^a   Nicol, David ^b   Clements, Judith ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

cDNA library; Kallikreins; Kidney; Renal cell carcinoma; Tumour marker

Indexed keywords

COMPLEMENTARY DNA; KALLIKREIN; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DNA LIBRARY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, RENAL CELL; FEMALE; GENE LIBRARY; HUMANS; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; PROSTATE-SPECIFIC ANTIGEN; RNA, MESSENGER; TISSUE KALLIKREINS; TRANSCRIPTION, GENETIC;

EID: 0032758094     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00059-4     Document Type: Article

References (14)

1. Chapdelaine P., Paradis G., Tremblay R.R., Dube J.Y. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Letters. 236:1988;205-208.
2. Clements J.A. The human kallikrein gene family: a diversity of expression and function. Molecular Cell Endocrinology. 99:1994;C1-C6.
3. Clements J.A., Mukhtar A. Glandular kallikreins and prostate specific antigen are expressed in the human endometrium. Journal Clinical Endocrinology Metabolism. 78:1994;1536-1539.
4. Clements J.A., Mukhtar A., Verity K., Pullar M., McNeill P., Cummins J., Fuller P.J. Kallikrein gene expression in human pituitary tissues. Clinical Endocrinology. 33:1996;223-231.
5. Clements J.A., Ward G., Kaushal A., Hii S.-I., Kennett C., Nicol D. A prostate specific antigen (PSA)-like protein associated with renal cell carcinoma in women. Clinical Cancer Research. 3:1997;1427-1431.
6. Diamandis E.P., Yu H., Sutherland D.J. Detection of prostate specific antigen immunoreactivity in breast tumours. Breast Cancer Research Treatment. 32:1994;301-310.
7. Elson P.J., Witte R.S., Trump D.L. Prognostic factors for survival in patients with recurrent or metastatic renal carcinoma. Cancer Research. 48:1988;7310-7313.
8. Fukushima D., Kitamura N., Nakanishi S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry. 24:1985;8037-8043.
9. Lovgren J., Pironen L., Overmo C., Dowell B., Karp M., Pettersson K., Lilja H., Lundwall A. Production of recombinant PSA and hK2 and analysis of their immunologic cross-reactivity. Biochemistry Biophysics Research Communications. 213:1995;888-895.
10. Maldazys J.D., deKernion J.B. Prognostic factors in metastatic renal carcinoma. Journal of Urology. 136:1986;376-379.
11. Pummer K., Wirnsberger G., Purstner P., Stettner H., Wandschneider G. False positive prostate specific antigen values in the sera of women with renal cell carcinoma. Journal of Urology. 148:1992;21-23.
12. Silverberg E., Boring C.C., Squires T.S. Cancer statistics 1990. CA Cancer Journal Clinical. 40:1990;9-26.
13. Vio C.P., Figueroa C.D. Subcellular localization of renal kallikrein by ultrastructural immunohistochemistry. Kidney International. 28:1985;36-42.
14. Watt K., Lee P.J., M'Timkulu T., Chan T.M., Loor R. Human prostate-specific antigen. Structural and functional similarity with serine proteases. Proceedings of the National Academy of Science. 83:1986;3166-3170.